These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 10843696)
1. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. Hoffmann KF; Cheever AW; Wynn TA J Immunol; 2000 Jun; 164(12):6406-16. PubMed ID: 10843696 [TBL] [Abstract][Full Text] [Related]
2. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. Hoffmann KF; James SL; Cheever AW; Wynn TA J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689 [TBL] [Abstract][Full Text] [Related]
3. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. Fallon PG; Richardson EJ; McKenzie GJ; McKenzie AN J Immunol; 2000 Mar; 164(5):2585-91. PubMed ID: 10679097 [TBL] [Abstract][Full Text] [Related]
4. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. Sandler NG; Mentink-Kane MM; Cheever AW; Wynn TA J Immunol; 2003 Oct; 171(7):3655-67. PubMed ID: 14500663 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA J Immunol; 2001 Dec; 167(11):6533-44. PubMed ID: 11714822 [TBL] [Abstract][Full Text] [Related]
6. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. Chiaramonte MG; Schopf LR; Neben TY; Cheever AW; Donaldson DD; Wynn TA J Immunol; 1999 Jan; 162(2):920-30. PubMed ID: 9916716 [TBL] [Abstract][Full Text] [Related]
7. Cross-regulatory role of interferon-gamma (IFN-gamma), IL-4 and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation. Chensue SW; Warmington KS; Ruth J; Lincoln PM; Kunkel SL Clin Exp Immunol; 1994 Dec; 98(3):395-400. PubMed ID: 7994903 [TBL] [Abstract][Full Text] [Related]
8. IFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. Hoffmann KF; Caspar P; Cheever AW; Wynn TA J Immunol; 1998 Oct; 161(8):4201-10. PubMed ID: 9780194 [TBL] [Abstract][Full Text] [Related]
9. Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. Fallon PG; Dunne DW J Immunol; 1999 Apr; 162(7):4122-32. PubMed ID: 10201937 [TBL] [Abstract][Full Text] [Related]
10. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Hesse M; Cheever AW; Jankovic D; Wynn TA Am J Pathol; 2000 Sep; 157(3):945-55. PubMed ID: 10980133 [TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni in IL-4-deficient mice. Pearce EJ; Cheever A; Leonard S; Covalesky M; Fernandez-Botran R; Kohler G; Kopf M Int Immunol; 1996 Apr; 8(4):435-44. PubMed ID: 8671630 [TBL] [Abstract][Full Text] [Related]
12. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Ward JM; Cheever AW; Paul WE; Sher A J Immunol; 1999 Jul; 163(1):337-42. PubMed ID: 10384133 [TBL] [Abstract][Full Text] [Related]
13. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. Wynn TA; Morawetz R; Scharton-Kersten T; Hieny S; Morse HC; Kühn R; Müller W; Cheever AW; Sher A J Immunol; 1997 Nov; 159(10):5014-23. PubMed ID: 9366429 [TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. Hesse M; Piccirillo CA; Belkaid Y; Prufer J; Mentink-Kane M; Leusink M; Cheever AW; Shevach EM; Wynn TA J Immunol; 2004 Mar; 172(5):3157-66. PubMed ID: 14978122 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection. Brunet LR; Beall M; Dunne DW; Pearce EJ J Immunol; 1999 Nov; 163(9):4976-84. PubMed ID: 10528202 [TBL] [Abstract][Full Text] [Related]
16. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation. Hernandez HJ; Wang Y; Stadecker MJ J Immunol; 1997 May; 158(10):4832-7. PubMed ID: 9144498 [TBL] [Abstract][Full Text] [Related]
17. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. Chiaramonte MG; Hesse M; Cheever AW; Wynn TA J Immunol; 2000 Jan; 164(2):973-85. PubMed ID: 10623847 [TBL] [Abstract][Full Text] [Related]
18. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice. Layland LE; Wagner H; da Costa CU Eur J Immunol; 2005 Nov; 35(11):3248-57. PubMed ID: 16276483 [TBL] [Abstract][Full Text] [Related]
19. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. Chiaramonte MG; Donaldson DD; Cheever AW; Wynn TA J Clin Invest; 1999 Sep; 104(6):777-85. PubMed ID: 10491413 [TBL] [Abstract][Full Text] [Related]
20. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4. Farah IO; Mola PW; Kariuki TM; Nyindo M; Blanton RE; King CL J Immunol; 2000 May; 164(10):5337-43. PubMed ID: 10799896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]